Molecular profiling improves classification and prognostication of nodal peripheral t-cell lymphomas: Results of a phase III diagnostic accuracy study

Journal of Clinical Oncology

Volumn 31, Issue 24, 2013, Pages 3019-3025

  Piccaluga, Pier Paolo ^a   Fuligni, Fabio ^a   De Leo, Antonio ^a   Bertuzzi, Clara ^a   Rossi, Maura ^a   Bacci, Francesco ^a   Sabattini, Elena ^a   Agostinelli, Claudio ^a   Gazzola, Anna ^a   Laginestra, Maria Antonella ^a   Mannu, Claudia ^a   Sapienza, Maria Rosaria ^a   Hartmann, Sylvia ^d   Hansmann, Martin L ^d   Piva, Roberto ^b   Iqbal, Javeed ^e   Chan, John C ^b   Weisenburger, Denis ^f   Vose, Julie M ^e   Bellei, Monica ^c   Federico, Massimo ^c   Inghirami, Giorgio ^b   Zinzani, Pier Luigi ^a   Pileri, Stefano A ^a   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; TRANSCRIPTOME;

ANAPLASTIC LARGE CELL LYMPHOMA; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERIPHERAL T CELL LYMPHOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SUPPORT VECTOR MACHINE; WORLD HEALTH ORGANIZATION; FEMALE; GENETICS; MALE; METABOLISM; PATHOLOGY; PROGNOSIS; SURVIVAL; TISSUE FIXATION;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FORMALDEHYDE; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; PARAFFIN EMBEDDING; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE FIXATION; TRANSCRIPTOME;

EID: 84887253698     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.5611     Document Type: Article

References (32)

1. Jaffe ES, Harris NL, Stein H, et al: Introduction and overview of the classification of the lymphoid neoplasms, in Swerdlow S, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues (ed IV). Lyon, France, IARC Press, 2008, pp 158-166
2. Federico M, Bellei M, Pesce E, et al: T-cell project: An international, prospective, observational study of patients with aggressive peripheral T-cell lymphoma-Analysis of first 524 patients. Presented at the 11th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 15-18, 2011
3. Savage KJ, Harris NL, Vose JM, et al: ALKanaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK- ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project. Blood 111: 5496-5504, 2008
4. Roncolato F, Gazzola A, Zinzani PL, et al: Targeted molecular therapy in peripheral T-cell lymphomas. Expert Rev Hematol 4:551-562, 2011
5. Hummel M, Bentink S, Berger H, et al: A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419-2430, 2006
6. Dave SS, Fu K, Wright GW, et al: Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354:2431-2442, 2006
7. Piccaluga PP, Agostinelli C, Califano A, et al: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 117:823-834, 2007
8. Piccaluga PP Agostinelli C Califano A et al: Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67: 10703-10710, 2007
9. de Leval L, Rickman DS, Thielen C, et al: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109:4952-4963, 2007
10. Iqbal J, Weisenburger DD, Greiner TC, et al: Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115: 1026-1036, 2010
11. Piva R, Agnelli L, Pellegrino E, et al: Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 28:1583-1590, 2010
12. Piccaluga PP, Agostinelli C, Zinzani PL, et al: Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified. Lancet Oncol 6:440, 2005
13. Piccaluga PP, De Falco G, Kustagi M, et al: Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 117:3596-3608, 2011
14. National Center for Biotechnology Information: Gene expression omnibus. http://www.ncbi.nlm.nih.gov/ projects/geo
15. Standards for the Reporting of Diagnostic Accuracy Studies: STARD statement. http://www.stardstatement. org
16. McShane LM, Altman DG, Sauerbrei W, et al: Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23:9067-9072, 2005
17. Whiting PF, Rutjes AW, Westwood ME, et al: QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529-536, 2011
18. Swerdlow S, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues (ed IV). Lyon, France, IARC Press, 2008
19. Kaplan E, Meier P: Non-parametric estimation from incomplete observation. JAMA 58:457-481, 1958
20. Pileri SA, Weisenburger DD, Sng I, et al: Peripheral T-cell lymphoma, not otherwise specified, in Swerdlow S, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues (ed IV). Lyon, France, IARC Press, 2008, pp 306-308
21. Dogan A, Gaulard P, Jaffe ES, et al: Angioimmunoblastic T-cell lymphoma, in Swerdlow S, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues (ed IV). Lyon, France, IARC Press, 2008, pp 309-311
22. Agostinelli C, Hartmann S, Klapper W, et al: Peripheral T cell lymphomas with follicular T helper phenotype: A new basket or a distinct entity? Revising Karl Lennert's personal archive. Histopathology 59:679-691, 2011
23. Piccaluga PP, Agostinelli C, Tripodo C, et al: Peripheral T-cell lymphoma classification: The matter of cellular derivation. Expert Rev Hematol 4:415-425, 2011
24. Cairns RA, Iqbal J, Lemonnier F, et al: IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119:1901-1903, 2012
25. Lemonnier F, Couronné L, Parrens M, et al: Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120:1466-1469, 2012
26. Feldman AL, Dogan A, Smith DI, et al: Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 117: 915-919, 2011
27. Martinez-Delgado B, Melé ndez B, Cuadros M, et al: Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 10:4971-4982, 2004
28. Ballester B, Ramuz O, Gisselbrecht C, et al: Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 25:1560-1570, 2006
29. Cuadros M, Dave SS, Jaffe ES, et al: Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 25:3321-3329, 2007
30. Went P, Agostinelli C, Gallamini A, et al: Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score. J Clin Oncol 24:2472-2479, 2006
31. April C, Klotzle B, Royce T, et al: Wholegenome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One 4:e8162, 2009
32. Waddell N, Cocciardi S, Johnson J, et al: Gene expression profiling of formalin-fixed, paraffinembedded familial breast tumours using the whole genome-DASL assay. J Pathol 221:452-461, 2010